BeautyHealth Excels in Q2 2025, Projects Increased Full-Year Outlook
The Beauty Health Company (NASDAQ: SKIN), the parent company of the renowned brand Hydrafacial, unveiled its impressive Q2 2025 financial results on August 7, 2025. The company reported a net sales figure of $78.2 million and significantly raised its full-year outlook, a move propelled by robust consumables sales and improved gross margins.
CEO Marla Beck underscored the company’s momentum, stating that BeautyHealth surpassed both revenue and Adjusted EBITDA projections while delivering substantial gross margin improvement. With an impressive count of over 35,000 active Hydrafacial devices globally and consumables contributing to more than 70% of the revenue, the company is witnessing the strength of its recurring revenue model.
Additionally, the company celebrated the successful launch of the HydraFillic with Pep9™ Booster and the continued standout performance of the Hydralock HA Booster. These achievements showcase the effectiveness of their innovation pipeline in the fiercely competitive medical aesthetics market.
Source: GlobeNewswire